Feature Identifier	Sequence Feature Name	Sequence Feature Length	Variant Types	Category	Amino Acid Position	Evidence	Comments	
Influenza A_N1_SF26	Influenza A_N1_active-site_148(19)	19	192	functional	148,181,182,254,306,322,401,436,149,186,208,209,228,252,257,304,307,324,455	PMID: 16912325, 8497041,	The active site of Influenza NA is made of the catalytic site residues which interact with the sialic acid substrate and the framework site residues that are indirectly involved in suporting the catalytic site. (PMID: 16912325). Framework residues stabilize the active-site structure	
Influenza A_N1_SF27	Influenza A_N1_catalytic-region-of-active-site_148(8)	8	56	functional	148,181,182,254,306,322,401,436	PMID: 16912325, 8497041,	-N/A-	
Influenza A_N1_SF28	Influenza A_N1_framework-region-of-active-site_149(11)	11	111	functional	149,186,208,209,228,252,257,304,307,324,455	PMID: 16912325, 8497041,	-N/A-	
Influenza A_N1_SF29	Influenza A_N1_calcium-binding-and-protein-stabilizing-site_324(1)	1	9	functional	324	UniProt: Q9IGQ6,	Site at which calcium ions bind to NA and renders stability to the protein	
Influenza A_N1_SF30	Influenza A_N1_calcium-binding-and-protein-stabilizing-site_294(1)	1	7	functional	294	UniProt: Q9IGQ6,	Site at which calcium ions bind to NA and renders stability to NA	
Influenza A_N1_SF31	Influenza A_N1_calcium-binding-and-protein-stabilizing-site_298(1)	1	8	functional	298	UniProt: Q9IGQ6,	Site at which calcium ions bind to NA and renders stability to NA	
Influenza A_N1_SF32	Influenza A_N1_calcium-binding-and-protein-stabilizing-site_344(1)	1	13	functional	344	UniProt: Q9IGQ6,	Site at which calcium ions bind to NA and renders stability to NA	
Influenza A_N1_SF33	Influenza A_N1_substrate-binding-and-hydrolysis-site_118(1)	1	9	functional	118	UniProt: Q9IGQ6,	Region at which NA binds to its substrate and catalyzes its hydrolysis	
Influenza A_N1_SF34	Influenza A_N1_substrate-binding-and-hydrolysis-site_293(1)	1	11	functional	293	UniProt: Q9IGQ6,	Region at which NA binds to its substrate and catalyzes its hydrolysis	
Influenza A_N1_SF35	Influenza A_N1_substrate-binding-and-hydrolysis-site_368(1)	1	5	functional	368	UniProt: Q9IGQ6,	Region at which NA binds to its substrate and catalyzes its hydrolysis	
Influenza A_N1_SF36	Influenza A_N1_determinant-of-oseltamivir-resistance_275(1)	1	9	sequence alteration	275	PMID: 12103431, 20194700 ,	Mutation at this position causes reduced sensitivity to the drug oseltamivir carboxylate.	
Influenza A_N1_SF37	Influenza A_N1_determinant-of-transmission_275(1)	1	9	sequence alteration	275	PMID: 12103431, 20194700 ,	Mutation at this position causes decreased infectivity and transmission of virus	
Influenza A_N1_SF38	Influenza A_N1_compensatory-mutation-for-H274Y-mutation_226(1)	1	6	sequence alteration	226	PMID: 20522774,	Introducing mutation R194G can compensate for the effects of H274Y mutation in NA (H274Y decreases surface expression of NA as well as reduces viral fitness) and thereby restore its activity. Therefore oseltamivir resistance is enabled by these permissive compensatory mutations that allow for subsequent H274Y mutations in the virus.	
Influenza A_N1_SF39	Influenza A_N1_determinant-of-host-range-specificity_38(43)	43	2436	sequence alteration	38..80	PMID: 8419645,	The length of the NA stalk affects the host range of influenza A viruses	
Influenza A_N1_SF304	Influenza A_N1_determinant-of-virulence_372(1)	1	6	functional	369	PMID: 10426210,	The five mutations (N369I in NA, K482R (silent mutation: G912A) in PB2, D538G in PB1, T139A (silent mutation: T121C) in M1 and W47G in HA2) control virulence and replicative capacity in mice.The PB1 and PB2 mutations are shown to be host restrictive in changing the virus to a mouse specific strain.	
Influenza A_N1_SF305	Influenza A_N1_determinants-of-virulence_49(20)	20	481	sequence alteration	49..68	PMID: 19609439, 16525739,	Recombinant virus with this NA-wild type stalk-motif display highest virulence and pathogenesis, while those with WSN-like, H5N1/97-like, H7N1/99-like, H5N1/96-like, PR/8-like, SA10, SD10 or SD20 stalk-motif display an attenuated phenotype, thus indicating that the NA stalk-motif is associated with virulence and pathogenesis of H5N1. influenza virus.	
Influenza A_N1_SF306	Influenza A_N1_determinant-of-virulence_469(1)	1	15	functional	469	PMID:  11533192,	The C-terminal Lys at this position is critical for virulence and its ability to replicate in the mouse. It supports plasminogen-binding activity which is critical for WSN virus neurotropism. 	
Influenza A_N1_SF307	Influenza A_N1_determinant-of-virulence_146(1)	1	13	functional	146	PMID: 8411368, 11533192,	The absence of a glycosylation site at position 130 of the NA plays a key role in the neurovirulence of WSN virus in mice.	
Influenza A_N1_SF308	Influenza A_N1_determinants-of-pathogenicity_146(2)	2	24	functional	146,469	PMID:  11533192,	The presence of a C-terminal Lys 453 and the lack of glycosylation at position 130 (146 in N2 numbering) are required for binding of the NA to plasminogen. 	
Influenza A_N1_SF309	Influenza A_N1_determinants-of-pathogenicity_49(20)	20	482	sequence alteration	49..68	PMID: 19609439,	Recombinant virus with this NA-wild type stalk-motif display highest virulence and pathogenesis, while those with WSN-like, H5N1/97-like, H7N1/99-like, H5N1/96-like, PR/8-like, SA10, SD10 or SD20 stalk-motif display an attenuated phenotype, thus indicating that the NA stalk-motif is associated with virulence and pathogenesis of H5N1 influenza virus.	
Influenza A_N1_SF312	Influenza A_N1_determinant-of-replication_469(1)	1	15	functional	469	PMID:  11533192,	The C-terminal Lys at this position is critical for virulence and its ability to replicate in the mouse. It supports plasminogen-binding activity which is critical for WSN virus neurotropism. 	
Influenza A_N1_SF313	Influenza A_N1_determinant-of-drug-resistance_275(1)	1	9	sequence alteration	275	PMID: 20686654,	275Y confers resistance to Oseltamivir	
Influenza A_N1_SF378	Influenza A_N1_determinant-of-virulence_49(20)	20	480	functional	49..68	PMID:19225004, PMID:19609439 ,	Introduction of a deletion known as the NA stalk motif in the A/chicken/Hubei/327/2004 backbone conferred increased virulence in mice and chicken indicated by the IVPI and lethality.	
Influenza A_N1_AVD_SF1	Influenza A_N1_antiviral-binding-site_4B7R_118(13)	13	119	functional	118..119,149..152,225,277..278,293,295,368,402	PMID: 23028314,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF2	Influenza A_N1_antiviral-binding-site_4B7Q_118(15)	15	101	functional	118..119,151..152,156,179,225,228,247,277..278,293,295,368,402	PMID: 23028314,	Zanamivir Binding Site	
Influenza A_N1_AVD_SF3	Influenza A_N1_antiviral-binding-site_4B7N_118(14)	14	93	functional	118..119,151..152,156,179,225,228,247,277..278,293,368,402	PMID: 23028314,	Zanamivir Binding Site	
Influenza A_N1_AVD_SF4	Influenza A_N1_antiviral-binding-site_4B7J_118(11)	11	80	functional	118..119,151..152,223,225,277..278,293,368,402	PMID: 23028314,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF5	Influenza A_N1_antiviral-binding-site_3TI6_118(11)	11	72	functional	118..119,151..152,179,225,277,293,295,368,402	PMID: 22028647,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF6	Influenza A_N1_antiviral-binding-site_3TI5_118(15)	15	101	functional	118..119,151..152,156,179,225,228,247,277..278,293,295,368,402	PMID: 22028647,	Zanamivir Binding Site	
Influenza A_N1_AVD_SF7	Influenza A_N1_antiviral-binding-site_3TI3_118(15)	15	101	functional	118..119,151..152,156,179,225,228,247,277..278,293,295,368,402	PMID: 22028647,	Laninamivir Binding Site	
Influenza A_N1_AVD_SF8	Influenza A_N1_antiviral-binding-site_3CL2_118(13)	13	104	functional	118..119,151..152,179,225,247,277..278,293,344,368,402	PMID: 18480754,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF9	Influenza A_N1_antiviral-binding-site_3CL0_118(10)	10	84	functional	118..119,151..152,277,293,295,344,368,402	PMID: 18480754,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF10	Influenza A_N1_antiviral-binding-site_3CKZ_118(16)	16	129	functional	118..119,151..152,156,179,225,228,247,277..278,293,295,344,368,402	PMID: 18480754,	Zanamivir Binding Site	
Influenza A_N1_AVD_SF11	Influenza A_N1_antiviral-binding-site_3B7E_118(14)	14	93	functional	118..119,151..152,156,179,225,228,247,277..278,293,368,402	PMID: 18715929,	Zanamivir Binding Site	
Influenza A_N1_AVD_SF12	Influenza A_N1_antiviral-binding-site_2HU4_118(14)	14	114	functional	118..119,151..152,179,225,247,277..278,293,295,344,368,402	PMID: 16915235,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF13	Influenza A_N1_antiviral-binding-site_2HU0_118(10)	10	81	functional	118,152,225,277..278,293,295,344,368,402	PMID: 16915235,	Oseltamivir Binding Site	
Influenza A_N1_AVD_SF380	Influenza A_N1_antiviral-response_117(1)	1	11	functional	117	PMID:17112602, PMID:20523902, PMID:18836532 ,	A/Chicken/Indonesia/Wates/77/2005 isolate with Ile97Val substitution conferred decreased sensitivity to oseltamivir using fluorescence based NA enzyme inhibition assay.	
Influenza A_N1_AVD_SF381	Influenza A_N1_antiviral-response_149(1)	1	15	functional	149	PMID:21343450,	Introduction of Val129Ala substitution in the A/CAM/408008/2005 backbone conferred decreased sensitivity to zanamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF382	Influenza A_N1_antiviral-response_156(1)	1	10	functional	156	PMID:22379077,	Introduction of Arg156Lys naturally occurring substitution in the A/Hong Kong/213/03 backbone conferred resistance to oseltamivir, peramivir and zanamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF383	Influenza A_N1_antiviral-response_199(1)	1	10	functional	199	PMID: 21288815,	A/New York/4438/2009 isolate contained the Asp199Asn substitution that conferred decreased sensitivity to oseltamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF385	Influenza A_N1_antiviral-response_278(1)	1	8	functional	278	PMID:17296744,	Introduction of Glu258Gln naturally occurring substitution in the A/Vietnam/1203/2004 backbone decreased oseltamivir sensitivity using plaque reduction assay in MDCK cells.	
Influenza A_N1_AVD_SF387	Influenza A_N1_antiviral-response_223(1)	1	12	functional	223	PMID: 21801626;  20858074; 20879894,	Compared to A/California/07/2009, A/Ontario/313762/2009(H1N1) isolate contained the Ile223Arg substitution that conferred decreased sensitivity to oseltamivir, zanamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF397	Influenza A_N1_antiviral-response_136(1)	1	8	functional	136	PMID: 19917319; 19641000 ,	Introduction of Gln136Lys naturally occurring substitution in the A/Panama/1310/2008 backbone conferred reduced susceptibility to zanamivir and peramivir.	
Influenza A_N1_AVD_SF401	Influenza A_N1_antiviral-response_119(1)	1	10	functional	119	PMID: 19651908; 21148493,	Introduction of  Glu119Gly substitution in the A/Quebec/144147/09 backbone conferred resistance to oseltamivir, zanamivir and peramivir using NA inhibition assay. 	
Influenza A_N1_AVD_SF402	Influenza A_N1_antiviral-response_136(1)	1	8	functional	136	PMID: 20603155,	Introduction of Gln116Leu naturally occurring substitution in the A/Vietnam/1203/2004 backbone conferred oseltamivir and zanamivir resistance using fluorescence based enzyme inhibition assay.	
Influenza A_N1_AVD_SF404	Influenza A_N1_antiviral-response_119(1)	1	10	functional	119	PMID: 22379077; 17302366; 20523902; ,	Introduction of Glu99Ala naturally occurring substitution in the A/Turkey/65 1242/06 backbone conferred resistance to oseltamivir, zanamivir and peramivir. 	
Influenza A_N1_AVD_SF407	Influenza A_N1_antiviral-response_275(1)	1	8	functional	275	PMID: 19651908; 1170976;  17296744; 18368779; 19022400;  16228009; 16371632; ,	Introduction of His255Tyr naturally occurring substitution in the A/Vietnam/1203/2004 backbone conferred decreased oseltamivir sensitivity as indicated by measuring inhibition of neuraminidase activity.	
Influenza A_N1_AVD_SF429	Influenza A_N1_antiviral-response_223(2)	2	17	functional	223,297	PMID: 21148493; 17302366; 20016036; 20858074 ,	Introduction of Ile203Val and His277Tyr  substitutions in the A/Pennsylvania/30/2009 backbone conferred decreased sensitivity to oseltamivir, peramivir using NA inhibitors.	
Influenza A_N1_AVD_SF430	Influenza A_N1_antiviral-response_223(1)	1	12	functional	223	PMID: 19651908; 21148493; 17302366; 20016036; 20858074 ,	Introduction of  Ile203Met substitutions in the A/Chicken/Laos/26/2006 backbone conferred decreased sensitivity to oseltamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF431	Influenza A_N1_antiviral-response_116(1)	1	9	functional	116	PMID: 20016036; 20523902; 17112602;  ,	Introduction of Val95Ala substitution in the A/Turkey/15/2006 backbone conferred decreased sensitivity to oseltamivir and zanamivir using NA inhibition assay and measuring NA enzyme kinetics.  	
Influenza A_N1_AVD_SF432	Influenza A_N1_antiviral-response_295(1)	1	10	functional	295	PMID: 20701864; 21367898; 19022400; 21148493 ; 17855542; ,	Asn275Ser substitution found in  A/Egypt/1425 NAMRU3/2006 isolate conferred decreased oseltamivir sensitivity from patients treated with oseltamivir, increased replication in ferrets.  	
Influenza A_N1_AVD_SF433	Influenza A_N1_antiviral-response_223(1)	1	12	functional	223	PMID: 19651908; 21148493; 17302366; 20016036; 20858074 ,	Introduction of  Ile203Val substitutions in the A/Chicken/Laos/26/2006 backbone conferred decreased sensitivity to oseltamivir using NA inhibition assay.	
Influenza A_N1_AVD_SF434	Influenza A_N1_antiviral-response_223(2)	2	17	functional	223,297	PMID: 21148493; 17302366; 20016036; 20858074 ,	Introduction of Ile203Arg and His277Tyr substitutions in the A/Pennsylvania/30/2009 backbone conferred decreased sensitivity to oseltamivir, zanamivir, peramivir using NA inhibitors.	
Influenza A_N1_AVD_SF435	Influenza A_N1_antiviral-response_223(2)	2	17	functional	223,297	PMID: 21148493; 17302366; 20016036; 20858074 ,	Introduction of Ile203Met and His277Tyr  substitutions in the A/Pennsylvania/30/2009 backbone conferred decreased sensitivity to oseltamivir, peramivir using NA inhibitors.	
Influenza A_N1_AVD_SF436	Influenza A_N1_antiviral-response_247(1)	1	9	functional	247	PMID: 20016036,	A/chicken/Laos/13/08 isolate with Ser227Asn substitution conferred decreased oseltamivir sensitivity using NA inhibition assay	
